These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27796300)

  • 1. PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation.
    Iwata H; Goettsch C; Sharma A; Ricchiuto P; Goh WW; Halu A; Yamada I; Yoshida H; Hara T; Wei M; Inoue N; Fukuda D; Mojcher A; Mattson PC; Barabási AL; Boothby M; Aikawa E; Singh SA; Aikawa M
    Nat Commun; 2016 Oct; 7():12849. PubMed ID: 27796300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Study into the ADP-Ribosylome of IFN-γ-Stimulated THP-1 Human Macrophage-like Cells Identifies ARTD8/PARP14 and ARTD9/PARP9 ADP-Ribosylation.
    Higashi H; Maejima T; Lee LH; Yamazaki Y; Hottiger MO; Singh SA; Aikawa M
    J Proteome Res; 2019 Apr; 18(4):1607-1622. PubMed ID: 30848916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARP14 is regulated by the PARP9/DTX3L complex and promotes interferon γ-induced ADP-ribosylation.
    Ribeiro VC; Russo LC; Hoch NC
    EMBO J; 2024 Jul; 43(14):2908-2928. PubMed ID: 38834852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.
    Saleh H; Liloglou T; Rigden DJ; Parsons JL; Grundy GJ
    J Mol Biol; 2024 Feb; 436(4):168434. PubMed ID: 38182103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP14 is a writer, reader, and eraser of mono-ADP-ribosylation.
    Torretta A; Chatzicharalampous C; Ebenwaldner C; Schüler H
    J Biol Chem; 2023 Sep; 299(9):105096. PubMed ID: 37507011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation.
    Kar P; Chatrin C; Đukić N; Suyari O; Schuller M; Zhu K; Prokhorova E; Bigot N; Baretić D; Ahel J; Elsborg JD; Nielsen ML; Clausen T; Huet S; Niepel M; Sanyal S; Ahel D; Smith R; Ahel I
    EMBO J; 2024 Jul; 43(14):2929-2953. PubMed ID: 38834853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling.
    Russo LC; Tomasin R; Matos IA; Manucci AC; Sowa ST; Dale K; Caldecott KW; Lehtiö L; Schechtman D; Meotti FC; Bruni-Cardoso A; Hoch NC
    J Biol Chem; 2021 Sep; 297(3):101041. PubMed ID: 34358560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
    Yang CS; Jividen K; Spencer A; Dworak N; Ni L; Oostdyk LT; Chatterjee M; Kuśmider B; Reon B; Parlak M; Gorbunova V; Abbas T; Jeffery E; Sherman NE; Paschal BM
    Mol Cell; 2017 May; 66(4):503-516.e5. PubMed ID: 28525742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear ADP-ribosylation drives IFNγ-dependent STAT1α enhancer formation in macrophages.
    Gupte R; Nandu T; Kraus WL
    Nat Commun; 2021 Jun; 12(1):3931. PubMed ID: 34168143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-ADP ribose polymerase-14 limits severity of allergic skin disease.
    Krishnamurthy P; Da-Silva-Arnold S; Turner MJ; Travers JB; Kaplan MH
    Immunology; 2017 Nov; 152(3):451-461. PubMed ID: 28653395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A potent and selective PARP14 inhibitor decreases protumor macrophage gene expression and elicits inflammatory responses in tumor explants.
    Schenkel LB; Molina JR; Swinger KK; Abo R; Blackwell DJ; Lu AZ; Cheung AE; Church WD; Kunii K; Kuplast-Barr KG; Majer CR; Minissale E; Mo JR; Niepel M; Reik C; Ren Y; Vasbinder MM; Wigle TJ; Richon VM; Keilhack H; Kuntz KW
    Cell Chem Biol; 2021 Aug; 28(8):1158-1168.e13. PubMed ID: 33705687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Degradation of PARP14 Using a Heterobifunctional Small Molecule.
    Wigle TJ; Ren Y; Molina JR; Blackwell DJ; Schenkel LB; Swinger KK; Kuplast-Barr K; Majer CR; Church WD; Lu AZ; Mo J; Abo R; Cheung A; Dorsey BW; Niepel M; Perl NR; Vasbinder MM; Keilhack H; Kuntz KW
    Chembiochem; 2021 Jun; 22(12):2107-2110. PubMed ID: 33838082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of poly(ADP-ribose) polymerase 9 (PARP9) as a noncanonical sensor for RNA virus in dendritic cells.
    Xing J; Zhang A; Du Y; Fang M; Minze LJ; Liu YJ; Li XC; Zhang Z
    Nat Commun; 2021 May; 12(1):2681. PubMed ID: 33976210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family.
    Cho SH; Ahn AK; Bhargava P; Lee CH; Eischen CM; McGuinness O; Boothby M
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):15972-7. PubMed ID: 21911376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.
    Ashok Y; Vela-Rodríguez C; Yang C; Alanen HI; Liu F; Paschal BM; Lehtiö L
    Biochem J; 2022 Feb; 479(3):289-304. PubMed ID: 35037691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combining Chemical Genetics with Proximity-Dependent Labeling Reveals Cellular Targets of Poly(ADP-ribose) Polymerase 14 (PARP14).
    Carter-O'Connell I; Vermehren-Schmaedick A; Jin H; Morgan RK; David LL; Cohen MS
    ACS Chem Biol; 2018 Oct; 13(10):2841-2848. PubMed ID: 30247868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP14 is a PARP with both ADP-ribosyl transferase and hydrolase activities.
    Đukić N; Strømland Ø; Elsborg JD; Munnur D; Zhu K; Schuller M; Chatrin C; Kar P; Duma L; Suyari O; Rack JGM; Baretić D; Crudgington DRK; Groslambert J; Fowler G; Wijngaarden S; Prokhorova E; Rehwinkel J; Schüler H; Filippov DV; Sanyal S; Ahel D; Nielsen ML; Smith R; Ahel I
    Sci Adv; 2023 Sep; 9(37):eadi2687. PubMed ID: 37703374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14).
    Schweiker SS; Tauber AL; Sherry ME; Levonis SM
    Mini Rev Med Chem; 2018; 18(19):1659-1669. PubMed ID: 30112992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAL1/ARTD9 represses the anti-proliferative and pro-apoptotic IFNγ-STAT1-IRF1-p53 axis in diffuse large B-cell lymphoma.
    Camicia R; Bachmann SB; Winkler HC; Beer M; Tinguely M; Haralambieva E; Hassa PO
    J Cell Sci; 2013 May; 126(Pt 9):1969-80. PubMed ID: 23487038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
    Wijngaarden S; Yang C; Vela-Rodríguez C; Lehtiö L; Overkleeft HS; Paschal BM; Filippov DV
    ACS Chem Biol; 2023 Nov; 18(11):2377-2384. PubMed ID: 37939374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.